Mechanisms of Linezolid Resistance in Mycobacteria

Mycobacteria form some of the most notorious and difficult-to-treat bacterial pathogens. As a group, they are intrinsically resistant to many commonly used antibiotics, such as tetracyclines and beta-lactams. In addition to intrinsic resistances, acquired multidrug resistance has also been observed...

Full description

Bibliographic Details
Main Authors: Wei Chong Gan, Hien Fuh Ng, Yun Fong Ngeow
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/16/6/784
_version_ 1797593115113029632
author Wei Chong Gan
Hien Fuh Ng
Yun Fong Ngeow
author_facet Wei Chong Gan
Hien Fuh Ng
Yun Fong Ngeow
author_sort Wei Chong Gan
collection DOAJ
description Mycobacteria form some of the most notorious and difficult-to-treat bacterial pathogens. As a group, they are intrinsically resistant to many commonly used antibiotics, such as tetracyclines and beta-lactams. In addition to intrinsic resistances, acquired multidrug resistance has also been observed and documented in <i>Mycobacterium tuberculosis</i> (MTB)<i>, Mycobacterium leprae</i> and non-tuberculous mycobacteria (NTM). To combat multidrug resistant infections by these pathogens, innovative antimicrobials and treatment regimens are required. In this regard, linezolid, an oxazolidinone introduced for clinical use just two decades ago, was added to the therapeutic armamentarium for drug-resistant mycobacteria. It exhibits antibacterial activity by binding to the 50S ribosomal subunit and inhibiting protein synthesis. Unfortunately, linezolid resistance has now been documented in MTB and NTM, in many parts of the world. Most linezolid-resistant mycobacterial strains show mutations in the ribosome or related genes, such as in the <i>rplC, rrl</i> and <i>tsnR</i> genes. Non-ribosomal mechanisms appear to be rare. One such mechanism was associated with a mutation in <i>fadD32</i>, which encodes a protein that plays an important role in mycolic acid synthesis. Mycobacterial efflux proteins have also been implicated in linezolid resistance. This review summarises current knowledge of genetic determinants of linezolid resistance in mycobacteria, with the aim of contributing information that could facilitate the discovery of new therapeutic approaches to overcome, delay or avoid further developments of drug resistance among these important pathogens.
first_indexed 2024-03-11T02:03:15Z
format Article
id doaj.art-754999ca56f24b1597f406f91b68a083
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-11T02:03:15Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-754999ca56f24b1597f406f91b68a0832023-11-18T12:01:27ZengMDPI AGPharmaceuticals1424-82472023-05-0116678410.3390/ph16060784Mechanisms of Linezolid Resistance in MycobacteriaWei Chong Gan0Hien Fuh Ng1Yun Fong Ngeow2Dr. Wu Lien-Teh Centre for Research in Communicable Diseases, M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Jalan Sungai Long, Bandar Sungai Long, Kajang 43000, Selangor, MalaysiaDr. Wu Lien-Teh Centre for Research in Communicable Diseases, M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Jalan Sungai Long, Bandar Sungai Long, Kajang 43000, Selangor, MalaysiaDr. Wu Lien-Teh Centre for Research in Communicable Diseases, M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Jalan Sungai Long, Bandar Sungai Long, Kajang 43000, Selangor, MalaysiaMycobacteria form some of the most notorious and difficult-to-treat bacterial pathogens. As a group, they are intrinsically resistant to many commonly used antibiotics, such as tetracyclines and beta-lactams. In addition to intrinsic resistances, acquired multidrug resistance has also been observed and documented in <i>Mycobacterium tuberculosis</i> (MTB)<i>, Mycobacterium leprae</i> and non-tuberculous mycobacteria (NTM). To combat multidrug resistant infections by these pathogens, innovative antimicrobials and treatment regimens are required. In this regard, linezolid, an oxazolidinone introduced for clinical use just two decades ago, was added to the therapeutic armamentarium for drug-resistant mycobacteria. It exhibits antibacterial activity by binding to the 50S ribosomal subunit and inhibiting protein synthesis. Unfortunately, linezolid resistance has now been documented in MTB and NTM, in many parts of the world. Most linezolid-resistant mycobacterial strains show mutations in the ribosome or related genes, such as in the <i>rplC, rrl</i> and <i>tsnR</i> genes. Non-ribosomal mechanisms appear to be rare. One such mechanism was associated with a mutation in <i>fadD32</i>, which encodes a protein that plays an important role in mycolic acid synthesis. Mycobacterial efflux proteins have also been implicated in linezolid resistance. This review summarises current knowledge of genetic determinants of linezolid resistance in mycobacteria, with the aim of contributing information that could facilitate the discovery of new therapeutic approaches to overcome, delay or avoid further developments of drug resistance among these important pathogens.https://www.mdpi.com/1424-8247/16/6/784<i>Mycobacterium tuberculosis</i>non-tuberculous mycobacteria<i>Mycobacteroides abscessus</i>linezolid resistancegenetic determinants
spellingShingle Wei Chong Gan
Hien Fuh Ng
Yun Fong Ngeow
Mechanisms of Linezolid Resistance in Mycobacteria
Pharmaceuticals
<i>Mycobacterium tuberculosis</i>
non-tuberculous mycobacteria
<i>Mycobacteroides abscessus</i>
linezolid resistance
genetic determinants
title Mechanisms of Linezolid Resistance in Mycobacteria
title_full Mechanisms of Linezolid Resistance in Mycobacteria
title_fullStr Mechanisms of Linezolid Resistance in Mycobacteria
title_full_unstemmed Mechanisms of Linezolid Resistance in Mycobacteria
title_short Mechanisms of Linezolid Resistance in Mycobacteria
title_sort mechanisms of linezolid resistance in mycobacteria
topic <i>Mycobacterium tuberculosis</i>
non-tuberculous mycobacteria
<i>Mycobacteroides abscessus</i>
linezolid resistance
genetic determinants
url https://www.mdpi.com/1424-8247/16/6/784
work_keys_str_mv AT weichonggan mechanismsoflinezolidresistanceinmycobacteria
AT hienfuhng mechanismsoflinezolidresistanceinmycobacteria
AT yunfongngeow mechanismsoflinezolidresistanceinmycobacteria